ATRICURE
Biotechnology company for the treatment of atrial fibrillation and related conditions
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 4 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
POLSINELLI PC | — reported |
|
Registration 3rd Quarter 2026
|
POLSINELLI PC | — reported |
|
3rd Quarter - Termination 3rd Quarter 2026
|
FOLEY HOAG LLP | $10,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
FOLEY HOAG LLP | $20,000 reported |
|
1st Quarter - Report 1st Quarter 2026
|
FOLEY HOAG LLP | $20,000 reported |
|
4th Quarter - Report 4th Quarter 2025
|
FOLEY HOAG LLP | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2025
|
FOLEY HOAG LLP | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2025
|
FOLEY HOAG LLP | $22,500 reported |
|
1st Quarter - Report 1st Quarter 2025
|
FOLEY HOAG LLP | $18,000 reported |
|
4th Quarter - Report 4th Quarter 2024
|
FOLEY HOAG LLP | $22,500 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FOLEY HOAG LLP | 15 | $274,000 |
| DLA PIPER LLP (US) | 2 | $50,000 |
| HANCE SCARBOROUGH | 5 | $40,000 |
| POLSINELLI PC | 1 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medicare/Medicaid | MMM | 21 |
| Copyright/Patent/Trademark | CPT | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 1260 | 117th | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.